Blood Flow Restriction Following Hip Arthroscopy

Launched by RUSH UNIVERSITY MEDICAL CENTER · Oct 1, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called Blood Flow Restriction after hip surgery, specifically for patients with conditions like labral tears or femoral acetabular impingement. The study will compare the effects of this treatment with a placebo (an inactive substance) in patients who are scheduled for hip arthroscopy, a type of surgery used to treat hip joint issues. Participants will be randomly assigned to one of the two groups and will be followed up at 1 month, 3 months, 6 months, and 1 year after their surgery to see how well they recover.

To be eligible for this study, you need to be between 18 and 40 years old, speak English, and have a confirmed diagnosis that requires surgery on your hip. It’s important that you can attend follow-up appointments and understand the details of the study. Unfortunately, if you have had previous surgeries on the same hip or knee, or if you have certain medical conditions like blood clotting disorders, you may not be able to participate. This study is currently recruiting participants, and it aims to gather important information to help improve recovery methods after hip surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients 18-40
• • English-speaking
• • Clinical and radiographic examination (MRI) consistent FAIS and/or labral pathology, and are schedule for primary hip arthroscopy
• • Written and informed consent for study participation
• Exclusion Criteria:
• • Patients younger than 18 or older than 40 years of age
• • Non-native English speaker
• • Revision surgery or prior history of ipsilateral hip or knee surgery
• • Inability to comply with the proposed follow-up clinic visits
• • Patients lacking decisional capacity
• • Patients with a history of deep vein thrombosis, pulmonary embolism, or known clotting disorder or hypercoagulable state
• • Pregnant or breast-feeding women. Pregnancy as determined by a positive pregnancy test prior to procedure. Females of childbearing potential must agree to use an acceptable birth control method during study participation.
• • Worker's compensation patients
• • Any clinically significant finding that would place the patient at health risk, impact the study, or affect the completion of the study
• • Any psychiatric illness that would prevent comprehension of the details and nature of the study and interfere with follow-up clinic visits